Click Therapeutics
Click Therapeutics Leadership & Management
What People Are Saying About Click Therapeutics
-
Strategic Vision & Planning: Leadership consistently positions the company around developing, validating, and commercializing software as prescription medical treatments, spanning prescription digital therapeutics and “software‑enhanced drugs.” Directional messaging—partnership‑enabled development and a near‑term push on CT‑155—is clear and reiterated across public materials.
-
Strong Execution: Multiple programs have reached authorization or pivotal data in stated focus areas, including FDA clearance and launch of Rejoyn, FDA authorization of CT‑132, and CT‑155 meeting its Phase 3 primary endpoint. These milestones align with the stated focus and indicate operational follow‑through.
-
Collaborative & Aligned Leadership: The path to market relies on pharma partnerships for pivotal studies and commercialization, such as Otsuka for Rejoyn and Boehringer Ingelheim for CT‑155. A recent agreement and funding tied to CT‑155’s commercialization highlights coordinated movement from R&D to go‑to‑market.
Click Therapeutics's Benefits
Hosts in-person all-hands meetings
Implements team-based strategic planning
Open office floor plan to encourage communication and collaboration
Uses an OKR operational model to clearly define goals and priorities
Utilizes an open door policy that encourages accessibility
